These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17385349)

  • 1. Assessment of liver function in children with acute lymphoblastic leukemia in remission.
    Mokrzycka M; Pawlik A; Kałdońska M; Millo B
    Ann Acad Med Stetin; 2006; 52(3):61-5; discussion 65. PubMed ID: 17385349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
    Testa R; Caglieris S; Risso D; Arzani L; Campo N; Alvarez S; Giannini E; Lantieri PB; Celle G
    Am J Gastroenterol; 1997 Dec; 92(12):2268-73. PubMed ID: 9399768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lidocaine and its metabolite as a hepatic function marker in dogs.
    Pérez-Guillé BE; Villegas-Alvarez F; Toledo-López A; Jiménez-Bravo MA; González-Zamora JF; Carrasco-Portugal MC; Flores-Murrieta FJ; Soriano-Rosales RE
    Proc West Pharmacol Soc; 2011; 54():62-5. PubMed ID: 22423583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats.
    Gawrońska-Szklarz B; Musiał DH; Pawlik A; Paprota B
    Pol J Pharmacol; 2003; 55(4):619-24. PubMed ID: 14581721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
    J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lidocaine elimination and MEGX formation after oral lidocaine administration--a practicable test for assessment of quantitative liver function].
    Klinker H; Joeres R; Bomhard M; Keller F; Dorer J; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():52-5. PubMed ID: 7483715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of monoethylglycinexylidide as measure of liver function for patients with chronic viral hepatitis.
    Elin RJ; Fried MW; Sampson M; Ruddel M; Kleiner DE; DiBisceglie AM
    Clin Chem; 1997 Oct; 43(10):1952-7. PubMed ID: 9342018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemia presenting as acute hepatitis without liver failure.
    Rivet C; Leverger G; Jacquemin E; Bernard O
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):640-1. PubMed ID: 25003374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML; Luketic VA; Sanyal AJ; Thompson EB
    Ther Drug Monit; 1996 Aug; 18(4):372-7. PubMed ID: 8857553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis.
    El Desoky ES; Ahmed AM; Nafeh MA; Ahmed HA; Schütz E; Armstrong VW; Oellerich M
    Clin Biochem; 1999 Apr; 32(3):207-12. PubMed ID: 10383082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.
    Muñoz AE; Miguez C; Rubio M; Bartellini M; Levi D; Podestá A; Niselman V; Terg R
    Dig Dis Sci; 1999 Apr; 44(4):789-95. PubMed ID: 10219840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following trauma.
    Pea F; Licari M; Baldassarre M; Furlanut M
    Fundam Clin Pharmacol; 2002 Dec; 16(6):519-25. PubMed ID: 12685511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
    Neumann S; Frenz M; Streit F; Oellerich M
    Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoethylglycinexylidide (MEGX)-test. A test for the assessment of prognosis before and after liver transplantation].
    Reichel C; Wienkoop G; Nacke A; Spengler U
    Dtsch Med Wochenschr; 1995 Feb; 120(6):179-83. PubMed ID: 7851289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.